OCTANe and Cedars/Aspens Society forge partnership for Ophthalmology Technology Summit


OCTANeOCTANe and Cedars/Aspens Society recently announced that it has forged a partnership to enhance ophthalmic surgery offerings for its annual Ophthalmology Technology Summit (OTS) this year. The summit will take place June 29 at the Fashion Island Hotel in Newport Beach, Calif. and will gather ophthalmology technologists, researchers, clinicians and entrepreneurs.

Cedars/Aspens is a non-profit society that has anterior segment surgeon educators whose mission is to expand the knowledge of ophthalmic surgery while fostering excellence in patient care through clinical experience, peer-to-peer exchange and practice education.

“Our collaboration with OCTANe is an exciting one for Cedars/Aspens because it goes right to our ultimate goal, which is to help advance eye surgery toward better clinical outcomes and recovery,” Mitchell A. Jackson, president of Cedars/Aspens, said. “We are thrilled to help build energy and substance around that purpose, in an environment that can help bring fresh ideas and technologies into the OR.”

OTS 2018 offers a one-day forum that showcases innovations and creates partnerships between physicians, entrepreneurs, investors and other business entities that have a shared interest in advancing ophthalmology through technology.

“OTS 2018 is poised for groundbreaking productivity and success through out partnership with Cedars/Aspens, a lineup of luminaries in the field, and out business and investor network,” Bill Carpou, OCTANe’s CEO, said. “With more than 500 programs, OCTANe has facilitated more than $2.1 billion for healthcare and technology companies, including equity exits. We created and host the annual OTS event to provide an environment for productive engagement solely focused on ophthalmology in order to accelerate the flow of technological ideas, talent and capital in this very dynamic speciality.”

OTS 2018 will also have a focus on groundbreaking ophthalmic technology, unmet clinical needs and new business opportunities. Allergan’s CEO Brent Saunders will be a keynote speaker for an open discussion about technological innovation in ophthalmology. Panel discussions will also focus on “Innovation and Perspectives in Ophthalmology,” “Practice Technologies and Their Impact” and “The Changing Practice Landscape” with various speakers from the medical field.

NEW! Technology Track at DeviceTalks Boston

textadimage These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Speak Your Mind